-transparent.png){kind=logo}
Treatment of the solid Walker carcinosarcoma of the rat for a period of one year with cyclophosphamide (40 mg/kg at each passage; tumours were transplanted weekly) resulted in the formation of a cyclophosphamide-resistant tumour cell line. Without further treatment, animals injected with non-treated or cyclophosphamide pre-treated cells survived for 10 days on an average. After therapy with cyclophosphamide (2 x 38 mg/kg), rats with non-treated tumour cells survived 22 days whereas those with pre-treated tumours survived only for 17 days. Tumour cells which were shown to be sensitive in vivo also exhibited a larger reduction in 3H-thymidine and 3H-uridine incorporation in the in vitro short term test after incubation with urine from cyclophosphamide-treated rats or with 4-hydroperoxy-cyclophosphamide. The resistance to cyclophosphamide which was detected in animal experiments with Walker carcinosarcoma can therefore also be observed using the in vitro short term test.
M Volm, and
J Mattern, and
K Wayss
October 1979,
Blut,
M Volm, and
J Mattern, and
K Wayss
February 1995,
Laboratory animal science,
M Volm, and
J Mattern, and
K Wayss
April 1983,
British journal of cancer,
M Volm, and
J Mattern, and
K Wayss
January 1985,
Progress in clinical and biological research,
M Volm, and
J Mattern, and
K Wayss
January 1978,
Zeitschrift fur Krebsforschung und klinische Onkologie. Cancer research and clinical oncology,
M Volm, and
J Mattern, and
K Wayss
February 1978,
British journal of cancer,
M Volm, and
J Mattern, and
K Wayss
January 1984,
Food additives and contaminants,
M Volm, and
J Mattern, and
K Wayss
February 1984,
Cancer,
M Volm, and
J Mattern, and
K Wayss
February 1986,
Acta pharmacologica et toxicologica,
M Volm, and
J Mattern, and
K Wayss
March 1988,
British journal of cancer,
